Germany Biotechnology Market Summary, Competitive Analysis and Forecast, 2017-2026
Germany Biotechnology Market Summary, Competitive Analysis and Forecast, 2017-2026
Abstract
Summary
Biotechnology in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
- The German biotechnology market had total revenues of $27.2 billion in 2021, representing a compound annual growth rate (CAGR) of 24% between 2016 and 2021.
- The medical/healthcare segment generated the most revenue in 2021, with total revenues of $13.5 billion, equivalent to 49.7% of the market's overall value.
- The successful performance of the German market has historically been fueled by a strong private and public financial backing, a trend which has been accelerated in 2020 and 2021 as the COVID-19 pandemic has attracted significant investment in the global race to develop effective solutions to control the outbreak and protect citizens.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Germany
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Germany
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Germany biotechnology market with five year forecasts
Reasons to Buy
- What was the size of the Germany biotechnology market by value in 2021?
- What will be the size of the Germany biotechnology market in 2026?
- What factors are affecting the strength of competition in the Germany biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up Germany's biotechnology market?
Content
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the strengths of leading players?
7.4. What has been the rationale behind recent M&A activity?
8 Company Profiles
8.1. Bayer AG
8.2. Boehringer Ingelheim GmbH
8.3. BioNTech SE
8.4. Merck & Co., Inc.
8.5. MorphoSys AG
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Germany biotechnology industry value: $ billion, 2016–21
Table 2: Germany biotechnology industry category segmentation: % share, by value, 2016–2021
Table 3: Germany biotechnology industry category segmentation: $ billion, 2016-2021
Table 4: Germany biotechnology industry geography segmentation: $ billion, 2021
Table 5: Germany biotechnology industry value forecast: $ billion, 2021–26
Table 6: Bayer AG: key facts
Table 7: Bayer AG: Annual Financial Ratios
Table 8: Bayer AG: Key Employees
Table 9: Bayer AG: Key Employees Continued
Table 10: Boehringer Ingelheim GmbH: key facts
Table 11: Boehringer Ingelheim GmbH: Key Employees
Table 12: BioNTech SE: key facts
Table 13: BioNTech SE: Annual Financial Ratios
Table 14: BioNTech SE: Key Employees
Table 15: Merck & Co., Inc.: key facts
Table 16: Merck & Co., Inc.: Annual Financial Ratios
Table 17: Merck & Co., Inc.: Key Employees
Table 18: Merck & Co., Inc.: Key Employees Continued
Table 19: MorphoSys AG: key facts
Table 20: MorphoSys AG: Key Employees
Table 21: Germany size of population (million), 2017–21
Table 22: Germany gdp (constant 2005 prices, $ billion), 2017–21
Table 23: Germany gdp (current prices, $ billion), 2017–21
Table 24: Germany inflation, 2017–21
Table 25: Germany consumer price index (absolute), 2017–21
Table 26: Germany exchange rate, 2017–21
List of Figures
Figure 1: Germany biotechnology industry value: $ billion, 2016–21
Figure 2: Germany biotechnology industry category segmentation: $ billion, 2016-2021
Figure 3: Germany biotechnology industry geography segmentation: % share, by value, 2021
Figure 4: Germany biotechnology industry value forecast: $ billion, 2021–26
Figure 5: Forces driving competition in the biotechnology industry in Germany, 2021
Figure 6: Drivers of buyer power in the biotechnology industry in Germany, 2021
Figure 7: Drivers of supplier power in the biotechnology industry in Germany, 2021
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Germany, 2021
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Germany, 2021
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Germany, 2021
Summary
Biotechnology in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
- The German biotechnology market had total revenues of $27.2 billion in 2021, representing a compound annual growth rate (CAGR) of 24% between 2016 and 2021.
- The medical/healthcare segment generated the most revenue in 2021, with total revenues of $13.5 billion, equivalent to 49.7% of the market's overall value.
- The successful performance of the German market has historically been fueled by a strong private and public financial backing, a trend which has been accelerated in 2020 and 2021 as the COVID-19 pandemic has attracted significant investment in the global race to develop effective solutions to control the outbreak and protect citizens.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Germany
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Germany
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Germany biotechnology market with five year forecasts
Reasons to Buy
- What was the size of the Germany biotechnology market by value in 2021?
- What will be the size of the Germany biotechnology market in 2026?
- What factors are affecting the strength of competition in the Germany biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up Germany's biotechnology market?
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the strengths of leading players?
7.4. What has been the rationale behind recent M&A activity?
8 Company Profiles
8.1. Bayer AG
8.2. Boehringer Ingelheim GmbH
8.3. BioNTech SE
8.4. Merck & Co., Inc.
8.5. MorphoSys AG
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Germany biotechnology industry value: $ billion, 2016–21
Table 2: Germany biotechnology industry category segmentation: % share, by value, 2016–2021
Table 3: Germany biotechnology industry category segmentation: $ billion, 2016-2021
Table 4: Germany biotechnology industry geography segmentation: $ billion, 2021
Table 5: Germany biotechnology industry value forecast: $ billion, 2021–26
Table 6: Bayer AG: key facts
Table 7: Bayer AG: Annual Financial Ratios
Table 8: Bayer AG: Key Employees
Table 9: Bayer AG: Key Employees Continued
Table 10: Boehringer Ingelheim GmbH: key facts
Table 11: Boehringer Ingelheim GmbH: Key Employees
Table 12: BioNTech SE: key facts
Table 13: BioNTech SE: Annual Financial Ratios
Table 14: BioNTech SE: Key Employees
Table 15: Merck & Co., Inc.: key facts
Table 16: Merck & Co., Inc.: Annual Financial Ratios
Table 17: Merck & Co., Inc.: Key Employees
Table 18: Merck & Co., Inc.: Key Employees Continued
Table 19: MorphoSys AG: key facts
Table 20: MorphoSys AG: Key Employees
Table 21: Germany size of population (million), 2017–21
Table 22: Germany gdp (constant 2005 prices, $ billion), 2017–21
Table 23: Germany gdp (current prices, $ billion), 2017–21
Table 24: Germany inflation, 2017–21
Table 25: Germany consumer price index (absolute), 2017–21
Table 26: Germany exchange rate, 2017–21
List of Figures
Figure 1: Germany biotechnology industry value: $ billion, 2016–21
Figure 2: Germany biotechnology industry category segmentation: $ billion, 2016-2021
Figure 3: Germany biotechnology industry geography segmentation: % share, by value, 2021
Figure 4: Germany biotechnology industry value forecast: $ billion, 2021–26
Figure 5: Forces driving competition in the biotechnology industry in Germany, 2021
Figure 6: Drivers of buyer power in the biotechnology industry in Germany, 2021
Figure 7: Drivers of supplier power in the biotechnology industry in Germany, 2021
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Germany, 2021
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Germany, 2021
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Germany, 2021
Related Report
